Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6400
-0.0300 (-4.48%)
At close: Mar 17, 2026
Genetic Analysis AS Revenue
In the year 2025, Genetic Analysis AS had annual revenue of 21.17M NOK with 2.36% growth. Genetic Analysis AS had revenue of 6.83M in the quarter ending December 31, 2025, a decrease of -6.91%.
Revenue
21.17M NOK
Revenue Growth
+2.36%
P/S Ratio
2.14
Revenue / Employee
1.32M NOK
Employees
16
Market Cap
41.43M SEK
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.17M | 488.00K | 2.36% |
| Dec 31, 2024 | 20.68M | -2.48M | -10.71% |
| Dec 31, 2023 | 23.16M | 2.42M | 11.65% |
| Dec 31, 2022 | 20.75M | 7.37M | 55.08% |
| Dec 31, 2021 | 13.38M | 5.84M | 77.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lightning Group AB | 64.14M |
| QBNK Holding AB | 41.24M |
| Risk Intelligence | 39.66M |
| Redsense Medical AB | 26.80M |
| Touchtech AB | 22.42M |
| Vidhance AB | 17.99M |
| Tessin Nordic Holding AB | 14.80M |
| Monivent AB | 4.53M |